Quintis Stock Forecast, Price & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive QIN News and Ratings via Email

Sign-up to receive the latest news and ratings for Quintis and its competitors with MarketBeat's FREE daily newsletter.

Quintis logo

About Quintis

Quintis Limited, formerlyTFS Corporation Ltd, is engaged in the manufacture, sale, distribution, management, ownership and promotion of sandalwood plantations. The Company's segments include Plantation Management, Finance, Sandalwood Products and Pharmaceutical. The Plantation Management segment is responsible for the promotion and sales of Indian sandalwood lots to investors, called growers. The Plantation Management segment is also responsible for the establishment, maintenance and harvesting of Indian sandalwood plantations on behalf of the growers and group owned plantations. The Finance segment is responsible for providing finance to growers to purchase sandalwood lots. The Sandalwood Products segment is responsible for the manufacture of sandalwood oil and products for resale both domestic and internationally. The Pharmaceutical segment is responsible for research and development of pharmaceutical and biopharmaceutical products for commercializing.


No headlines for this company have been tracked by

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Quintis (ASX:QIN) Frequently Asked Questions

What stocks does MarketBeat like better than Quintis?

Wall Street analysts have given Quintis a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quintis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Quintis' earnings last quarter?

Quintis Limited (ASX:QIN) posted its quarterly earnings data on Tuesday, November, 14th. The company reported ($1.07) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.05 by $1.12.
View Quintis' earnings history

Who are Quintis' key executives?

Quintis' management team includes the following people:
  • Julius Luke Matthys, Interim Chief Executive Officer
  • Alistair Stevens, Chief Financial Officer
  • Paul Castella, Chief Executive Officer of Santalis Pharmaceuticals Inc
  • Quentin Heath Megson, General Manager - Operations and Corporate Services
  • Ian Ross Thompson, Senior Adviser
  • Simon Jonathan Storm, Corporate Secretary
  • Dalton Leslie Gooding, Independent Non-Executive Chairman of the Board (Age 59)
  • Giovanni Groppoli, Non-Executive Independent Director
  • Michael Graham Doveton Kay, Non-Executive Independent Director (Age 56)

What other stocks do shareholders of Quintis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quintis investors own include White Cliff Minerals (WCN) and (CAR).

What is Quintis' stock symbol?

Quintis trades on the ASX under the ticker symbol "QIN."

What is Quintis' official website?

The official website for Quintis is

Where are Quintis' headquarters?

How can I contact Quintis?

Quintis' mailing address is Old Brewery, L 2 171-173 Mounts Bay Rd, PERTH, WAS 6000, Australia. The company can be reached via phone at +61-8-92153000.

This page was last updated on 9/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.